BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//Centre for HIV Strategic Information - ECPv5.1.4//NONSGML v1.0//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:Centre for HIV Strategic Information
X-ORIGINAL-URL:https://www.hivevaluation.org
X-WR-CALDESC:Events for Centre for HIV Strategic Information
BEGIN:VTIMEZONE
TZID:UTC
BEGIN:STANDARD
TZOFFSETFROM:+0000
TZOFFSETTO:+0000
TZNAME:UTC
DTSTART:20240101T000000
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
DTSTART;TZID=UTC:20240513T080000
DTEND;TZID=UTC:20240517T170000
DTSTAMP:20260512T200345
CREATED:20240219T175344Z
LAST-MODIFIED:20240222T120605Z
UID:1543-1715587200-1715965200@www.hivevaluation.org
SUMMARY:Virtual Training Workshop on HIV strategic information and programme monitoring in key populations\, 13-17 May 2024
DESCRIPTION:Background\nThe global epidemic of HIV has led to unprecedented attention and commitment from governmements and the international community to improve access to HIV prevention and treatment. The need to better document the effectiveness of HIV prevention and treatment programmes and to do this with the most robust methods possible is widely recognized. Strategic information and monitoring and evaluation (M&E) systems enable a data-driven HIV response targeted towards populations in greatest needs of HIV prevention and treatment. \n\nLearning Objectives\nThe aim of this course is to provide participants with practical guidance on how to design and carry out surveillance and programme monitoring and evaluation in various population groups\, primarily in key populations. \nThe course starts with introductory presentations that describe concepts such as M&E framework\, logic models as well as components of an HIV surveillance and M&E system.  It will further outline key components of HIV surveillance and types of evaluation (process\, outcome and impact) and target-setting process for interventions‘ delivery that takes into consideration various types of data sources and evidence. \nThe course will present various methods and data sources that are used in surveillance and M&E such as routinely collected data on HIV prevention and treatment\, cross-sectional studies and more complex studies based on cohort\, step-wedged and randomized trial designs. Presentations will also describe various approaches to analysis of cascade of HIV prevention\, care and treatment services and its usefulness in understanding programme performance  The term “cascade” refers to the sequence of services needed to achieve desirable impacts and the gradual attrition of coverage of the eligible population at each step of the sequence. \n  \nKey topics: \n\nBasic principles and concepts of an HIV strategic information and M&E system\nApproaches and methods used to design HIV programme monitoring systems and evaluation studies (routine programmatic data collection\, cross-sectional studies\, cohort studies\, quasi-randomized trials\, randomized control trials)\nMonitoring and evaluation of ART programmes\, principles of cohort analysis\nImportance of process evaluation\nIndicators used to assess quality and coverage of HIV prevention\, care and  treatment\nPopulation size estimation methods (geographical mapping\, multiplier method and capture-recapture)\nAnalysis of the HIV prevention\, care and treatment cascade\nUsing evaluation to identify missed opportunities (services that are lacking\, population groups that are not addressed\, geographic areas not covered\, etc)\nEffective data dissemination techniques\n\n\nTeaching Methods\nThe course consists of lectures\, exercises and case studies. It is designed to provide participants with practical skills and knowledge in monitoring and evaluation of various components of comprehensive HIV prevention and treatment programmes. \nThe key part of the course is group/ individual work which consists of the development of a  draft protocol for evaluation of an intervention/ programme that participants will present at the end of the course. Participants can choose the topic of the evaluation protocol that they can later on use in their work. \n\nTarget Audience\nProfessionals working in HIV surveillance and evaluation of HIV prevention and treatment programmes\, partiuclarly in key populations. \n  \nTeaching Methods \nThe course consists of lectures\, presentation of case studies\, exercises and group work. \n\nDuration \nThe course will be conducted virtually via zoom\, from 13-17 May 2024. \n  \n  \nLecturers \nProfessor George W. Rutherford\, MD\, Institute for Global Health Sciences\, University of California\, San Francisco\, USA \nProfessor Ivana Bozicevic\, MD\, DrPH\, WHO Collaborating Centre for HIV Strategic Information\, School of Medicine\, University of Zagreb\, Croatia \nZoran Dominkovic\, WHO Collaborating Centre for HIV Strategic Information\, School of Medicine\, University of Zagreb\, Croatia \n  \n\n\n\n13 May 2024\n\n\n\n9.00-9.30\nWelcome and Introductions\n\n\n9.30-10.15\nPrinciples of HIV strategic information and programme monitoring and evaluation\n\n\n10.15-11.00\nImplementation of HIV surveillance and programme monitoring in key populations (1)\n\n\n10.45-11.00\nBreak\n\n\n11.00-11.45\nParticipants’ presentations: HIV surveillance and monitoring and evaluation systems in their countries \n\n\n11.45-12.30\nImplementation of HIV surveillance and programme monitoring in key populations (2)\n\n\n12.30-13.30\nLunch break \n\n\n13.30-14.00\nPrinciples of key population size estimation\n\n\n14.00-14.45\nExercise: Using IBBS and programmatic data to estimate coverage with HIV testing  services\n\n\n14.45-15.00\n Break\n\n\n15.00-16.00\nHIV impact indicators: measuring HIV incidence and mortality \n\n\n  \n14 May 2024\n\n\n\n9.00-9.45\nProgram logic models and their use in evaluation (with examples) \n\n\n9.45-10.30\nProcess evaluation  with examples \n\n\n10.30-10.45\nBreak\n\n\n10.45-11.30\nExercise: process evaluation\n\n\n11.30-12.30\nEvaluation study design (1): Cross-sectional study\n\n\n12.30-13.30\nLunch\n\n\n13.30-14.15\nExercise: cross-sectional studies\n\n\n14.15-15.00\nEvaluation study design (2): Cohort study design and longitudinal patient monitoring\n\n\n15.00-16.00\nEvaluation study design (3): Experimental and quasi-experimental study design \n\n\n\n  \n\n\n\n 15 May 2024\n\n\n\n9.00-9.45\nPopulation size estimation methods: Geographical mapping\n\n\n9.45-10.30\nPopulation size estimation methods: Multiplier method and capture-recapture \n\n\n10.30-10.45\nBreak\n\n\n10.45-11.30\nExercise: population size estimation\n\n\n11.30-12.30\nExamples of using programme and other routinely collected data for monitoring and evaluation of interventions  \nHIV testing\, PrEP\, needle and syringe exchange programmes\, viral load testing\, etc\n\n\n12.30-13.30\nLunch\n\n\n13.30-15.00\nWork on protocol development\n\n\n15.00-16.00\nLiterature review: Finding evidence on effectiveness of interventions\n\n\n  \n16 May 2024\n\n\n\n9.00-10.00\nHIV prevention cascade \n\n\n10.00-10.45\nHIV treatment cascade \n\n\n10.45-11.00\nBreak\n\n\n11.00-11.45\nModels of quality assurance and improvement of HIV services (Root Cause Analysis\, Site Improvement Through Monitoring System visits\, PDSA\, etc)\n\n\n11.45-12.30\nDissemination of evaluation findings\n\n\n12.30-13.30\nLunch\n\n\n13.30-16.30\nWork on the protocol development \nBreak\n\n\n  \n17 May 2024\n\n\n\n9.00-10.20\nPresentations of evaluation protocols \n\n\n10.20-10.40\nBreak\n\n\n10.40-12.30\nPresentations of evaluation protocols \n\n\n12.30-13.00\nEvaluations and closure\n\n\n\n  \n  \n
URL:https://www.hivevaluation.org/training-course/virtual-training-workshop-on-monitoring-and-evaluation-of-hiv-and-viral-hepatitis-prevention-and-treatment-programmes-13-17-may-2024/
END:VEVENT
END:VCALENDAR